Integrating New Therapies in the Treatment of Advanced Melanoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-012-0201-9.pdf
Reference38 articles.
1. Spiegel R, Naishadham D, Jemal A. CA Cancer J Clin. 2012;62:10–1.
2. Jemal A, Tiwari RC, Murray T, et al. American Cancer, Cancer statistics. CA Cancer J Clin. 2004;54:8–29.
3. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.
4. Chapman PB, Einhorn LH, Meyers ML, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999;17:2745–51.
5. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–23. The first randomized trial to show that treatment with ipilimumab improves survival in patients with advanced melanoma. This is the first agent to improve survival in this patient population.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Utilization of Surgery, Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed With Metastatic Melanoma;American Journal of Clinical Oncology;2015-06
2. Pharmacist's role in optimizing therapy of the newer agents for the treatment of metastatic melanoma;Melanoma Management;2015-02
3. Emerging targeted therapies for melanoma treatment (Review);International Journal of Oncology;2014-06-03
4. Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program;Journal for ImmunoTherapy of Cancer;2014
5. Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis;Journal of Investigative Dermatology;2013-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3